American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(65), 2021
DOI: 10.1128/aac.02172-20
Full text: Unavailable
The Mycobacterium tuberculosis drug discovery effort has generated a substantial number of new/repurposed drugs for therapy for this pathogen. The arrival of these drugs is welcome, but another layer of difficulty has emerged.